ストックスクリーナーアプリを入手
41.87
0.00%
0.00
前日終値:
$41.87
開ける：
$41.38
24時間の取引高:
1.68M
Relative Volume:
0.90
時価総額：
$3.31B
収益：
-
当期純損益:
$-119.67M
株価収益率:
-15.34
EPS:
-2.73
ネットキャッシュフロー:
$-97.30M
1週間 パフォーマンス:
+2.50%
1か月 パフォーマンス:
-3.46%
6か月 パフォーマンス:
+151.32%
1年 パフォーマンス:
+252.74%
1日の値動き範囲:
$40.50
$43.16
1週間の範囲:
$40.50
$45.62
52週間の値動き範囲:
$8.241
$47.65
Mineralys Therapeutics Inc Stock (MLYS) Company Profile
名前
Mineralys Therapeutics Inc
セクター
電話
(888) 378-6240
住所
150 N. RADNOR CHESTER ROAD, RADNOR
MLYS を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
MLYS
Mineralys Therapeutics Inc
|
41.87 | 3.31B | 0 | -119.67M | -97.30M | -2.73 |
|
VRTX
Vertex Pharmaceuticals Inc
|
426.76 | 107.15B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
755.90 | 77.46B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
436.38 | 58.90B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
918.92 | 56.55B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
198.76 | 42.58B | 447.02M | -1.18B | -906.14M | -6.1812 |
Mineralys Therapeutics Inc Stock (MLYS) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-06-11 | 開始されました | Jefferies | Hold |
| 2024-07-10 | 開始されました | H.C. Wainwright | Buy |
| 2024-04-02 | 開始されました | Goldman | Buy |
| 2023-03-07 | 開始されました | BofA Securities | Buy |
| 2023-03-07 | 開始されました | Credit Suisse | Outperform |
| 2023-03-07 | 開始されました | Evercore ISI | Outperform |
| 2023-03-07 | 開始されました | Guggenheim | Buy |
| 2023-03-07 | 開始されました | Stifel | Buy |
| 2023-03-07 | 開始されました | Wells Fargo | Overweight |
すべてを表示
Mineralys Therapeutics Inc (MLYS) 最新ニュース
Catalys Pacific fund sells Mineralys Therapeutics shares for $43.35m By Investing.com - Investing.com Australia
Director’s Major Stock Sale Shakes Up Mineralys Therapeutics! - TipRanks
Catalys Pacific fund sells Mineralys Therapeutics shares for $43.35m - Investing.com
Momentum divergence signals in Mineralys Therapeutics Inc. chartJuly 2025 Institutional & Weekly Stock Performance Updates - newser.com
What moving averages say about Mineralys Therapeutics Inc.Trade Exit Report & Community Consensus Picks - newser.com
How rising interest rates impact Mineralys Therapeutics Inc. stock2025 Risk Factors & Safe Capital Allocation Plans - newser.com
Will Mineralys Therapeutics Inc. stock benefit from commodity pricesNew Guidance & Free Safe Entry Trade Signal Reports - newser.com
Is Mineralys Therapeutics Inc. stock positioned for digital transformationTrade Performance Summary & Safe Swing Trade Setups - newser.com
How Mineralys Therapeutics Inc. stock performs in rate cut cyclesJuly 2025 Snapshot & AI Forecasted Entry/Exit Points - newser.com
Can Mineralys Therapeutics Inc. hit a new high this monthEarnings Performance Report & Free AI Powered Buy and Sell Recommendations - newser.com
Ranking Mineralys Therapeutics Inc. among high performing stocks via toolsEarnings Miss & Weekly Watchlist of Top Performers - newser.com
Is Mineralys Therapeutics Inc a good long term investmentAnalyst Upgrades & Free Tap Rapid Wealth - earlytimes.in
Mineralys Nears Pivotal FDA Filing as Hypertension Drug Lorundrostat Advances - MyChesCo
(MLYS) as a Liquidity Pulse for Institutional Tactics - news.stocktradersdaily.com
MLYS Stock Price Dives 11% After Mixed Securities Filing - StocksToTrade
Will Mineralys Therapeutics Inc. stock recover faster than marketJobs Report & High Accuracy Swing Entry Alerts - newser.com
How Mineralys Therapeutics Inc. stock reacts to Fed rate cutsJuly 2025 Selloffs & High Yield Equity Trading Tips - newser.com
Will Mineralys Therapeutics Inc. stock remain a Wall Street favoriteBear Alert & Real-Time Stock Movement Alerts - newser.com
Price action breakdown for Mineralys Therapeutics Inc.Trade Exit Summary & Real-Time Buy Zone Alerts - newser.com
Will Mineralys Therapeutics Inc. stock maintain growth story2025 Year in Review & Fast Gain Swing Trade Alerts - newser.com
Mineralys Therapeutics Inc. (MLYS) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade
Mineralys Therapeutics Shares Fall Following Executives' Stock Sale - MarketScreener
Mineralys Therapeutics’ Stock Dips Amid Earnings Miss - TipRanks
Mineralys Therapeutics director Karydas sells $689k in shares By Investing.com - Investing.com South Africa
Mineralys Therapeutics director Gold sells $1.57m in MLYS stock By Investing.com - Investing.com Nigeria
Has Mineralys Therapeutics Inc. found a price floorJuly 2025 Recap & Capital Efficient Trade Techniques - newser.com
Mineralys therapeutics (MLYS) CFO Adam Levy sells $5.36m in stock By Investing.com - Investing.com South Africa
Mineralys Therapeutics CEO Congleton sells $9 million in stock By Investing.com - Investing.com South Africa
Mineralys therapeutics (MLYS) CFO Adam Levy sells $5.36m in stock - Investing.com Nigeria
Mineralys Therapeutics Insider Sold Shares Worth $5,363,716, According to a Recent SEC Filing - MarketScreener
Insider Sell Alert: CEO Jon Congleton Sells 200,000 Shares of Mi - GuruFocus
Mineralys Therapeutics director Gold sells $1.57m in MLYS stock - Investing.com India
Mineralys Therapeutics director Karydas sells $689k in shares - Investing.com India
Mineralys Therapeutics CEO Congleton sells $9 million in stock - Investing.com India
Multi factor analysis applied to Mineralys Therapeutics Inc.Treasury Yields & Real-Time Stock Entry Alerts - newser.com
Mineralys at Stifel 2025 Healthcare Conference: Strategic Focus on Hypertension - Investing.com
Mineralys Therapeutics Inc (MLYS) 財務データ
収益
当期純利益
現金流量
EPS
1.38%
1.42%
大文字化:
|
ボリューム (24 時間):